Announced

Completed

Lallemand completed the acquisition of Evolva for CHF30m.

Synopsis

Lallemand, a privately owned company, founded at the end of the 19th century that researches, develops, produces and markets yeasts, bacteria and related products, completed the acquisition of Evolva, a biotech researching, developing and commercializing nature-based ingredients, for CHF30m.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite